ArticleMultiple sclerosis journal - experimental, translational and clinical

Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?

Zhifeng Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.